The presentation will focus on the application of high-pressure liquid chromatography with mass spectral detection (LC-MS/MS) as an aid to investigating the various stages of pharmaceutical research toward clinical development. LC-MS/MS theory, assay development, and Food and Drug Administration (FDA) acceptance criteria will be discussed along with the application of LC-MS/MS to cell culture, preclinical, and clinical trial studies, and its utility in metabolomics.